Related Experiment Video
Updated: Oct 18, 2026

Preparation of Acute Brain Slices Using an Optimized N-Methyl-D-glucamine Protective Recovery Method
Published on: February 26, 2018
Propofol suppresses intrinsic excitability and alters excitatory synaptic plasticity in ventral tegmental area
1Departments of Physiology, College of Medicine, Konyang University, Daejeon, the Republic of Korea.
Abstract:
Propofol (2,6-diisopropylphenol) is a short-acting intravenous anesthetic used to induce and maintain general anesthesia. Beyond its anesthetic actions, propofol can produce rewarding subjective effects and has abuse potential. Because ventral tegmental area (VTA) dopamine neurons contribute to reward processing and arousal, we examined the effects of propofol on their intrinsic and excitatory synaptic properties using whole-cell patch-clamp recordings in acute rat midbrain slices. At 100 μM, propofol reduced evoked action-potential firing and increased rheobase in putative VTA dopamine neurons. It also reduced the AMPA/NMDA ratio of glutamatergic synaptic currents. A spike-timing-dependent plasticity (STDP) protocol induced sustained long-term potentiation (LTP) under control conditions, whereas the same protocol in the presence of 100 μM propofol produced persistent LTD-like synaptic depression. These findings show that, under acute slice conditions, propofol alters intrinsic excitability, excitatory synaptic balance, and activity-dependent synaptic plasticity in putative VTA dopamine neurons. Whether these cellular effects contribute to propofol-related arousal or reward behaviors remains to be tested.
Related Concept Videos
Excitatory and Inhibitory Effects of Neurotransmitters
Parenteral Anesthetics: Overview
Drugs Affecting Neurotransmitter Synthesis
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Desensitization and Tachyphylaxis
Several...

